Aerospace and defense cost-reimbursable sales mix is cost-reimbursable contract sales divided by total sales.
Lockheed Martin reported $29.848 billion of cost-reimbursable sales in 2025, up from $28.315 billion in 2024.
Cost-reimbursable mix stayed near 40%
The category represented about 39.8% of 2025 sales, compared with roughly 39.9% in 2024.
That mirrors the stability of fixed-price sales mix and shows that Lockheed's overall contract-type composition changed very little year over year.
Reimbursement reduces some cost risk, not all program risk
Allowability rules, funding ceilings, schedule, technical performance, performance fees, cancellations, and customer decisions still matter.
The mix is a contract-risk classification, not a direct indicator of profitability or cash conversion.
Source:
Part of the Aerospace & Defense Program Economics
See It in Company Research
These companies are examples of how the concept is reported or discussed in public filings. Definitions can differ by issuer; these links open company research rather than a normalized metric comparison.
- LMTOpen operating-model research →12 of 12 reviewed concepts in Aerospace & Defense Program EconomicsContract and delivery mix4 of 4 bridge concepts supportedContinue through this bridge:Fixed-Price Sales MixProduct Sales MixServices Sales Mix
Continue Research
Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.
Compare aerospace and defense stocks
Compare cost-reimbursable mix with fixed-price mix as a contract-risk lens, not a direct margin or cash-conversion forecast.
Explore more topics in the Financial Research Encyclopedia.